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Summary
Inflammation is an important risk factor for cancer.
During inflammation, macrophages secrete nitric ox-
ide (NO•), which reacts with superoxide or oxygen to
create ONOO− or N2O3, respectively. Although homol-
ogous recombination causes DNA sequence re-
arrangements that promote cancer, little was known
about the ability of ONOO− and N2O3 to induce recom-
bination in mammalian cells. Here, we show that
ONOO− is a potent inducer of homologous recombi-
nation at an integrated direct repeat substrate, whereas
N2O3 is relatively weakly recombinogenic. Further-
more, on a per lesion basis, ONOO−-induced oxidative
base lesions and single-strand breaks are signifi-
cantly more recombinogenic than N2O3-induced base
deamination products, which did not induce detecta-
ble recombination between plasmids. Similar results
were observed in mammalian cells from two different
species. These results suggest that ONOO−-induced
recombination may be an important mechanism un-
derlying inflammation-induced cancer.
Introduction
Nitric oxide (NO•) is a key mediator of diverse biological
processes, including vasodilation, neurotransmission,
endotoxic shock, cerebral ischemia, and inflammation
[1–3]. At low concentrations, NO• is involved in intra-
and intercellular signaling, while at high concentrations,
NO• is toxic [4–6]. As a cytotoxic agent, NO• is secreted
by activated macrophages, along with oxygen radicals
and other cytotoxic chemicals during the inflammatory
response. Importantly, tissue inflammation associated
with gastritis, hepatitis, and colitis is an important risk
factor for a variety of human cancers, such as gastric
cancer, liver cancer, and cholangiocarcinoma [7]. Fur-
thermore, it is estimated that w15% of cancer cases
worldwide are attributable to infectious diseases, many
of which induce chronic inflammation [8]. Although the
underlying mechanism of inflammation-induced cancer
is not yet fully understood, exposure of tissues to re-
active oxygen and nitrogen species is thought to cause
mutations and genetic rearrangements that contribute
to tumor initiation and progression. While NO•-induced
point mutations have been studied extensively (e.g.,*Correspondence: bevin@mit.edusee references [9–11]), very little is known about the
ability of NO• to induce other classes of mutations,
such as sequence rearrangements that are mediated
by homologous recombination.
Mitotic homologous recombination allows cells to re-
pair DNA double-strand breaks by extracting missing
sequence information from a sister chromatid (during
S and G2 phases of cell cycle) or from a homologous
chromosome. In addition, homologous recombination
plays a critical role in restoring collapsed forks during
DNA replication (for excellent reviews of homologous
recombination, see references [12–14]). Although ho-
mologous recombination is generally highly accurate,
transfer of genetic material carries with it a finite risk of
a deliterious rearrangement, since recombination be-
tween misaligned sequences can lead to insertions,
deletions, inversions, and translocations. In addition,
exchanges between homologous chromosomes are re-
sponsible for causing most spontaneous loss of hetero-
zygosity events in mammals [15, 16]. Nearly all tumors
carry sequence rearrangements that are likely the result
of mitotic homologous recombination. Consequently,
whether by exposure to endogenous and environmen-
tal recombinogens, or by inherited predisposition, con-
ditions that lead to increased levels of homologous re-
combination are associated with an increased risk of
cancer [17–19].
Very little is known about the recombinogenicity of
NO• and its derivative reactive nitrogen species in
mammals. However, there are a few studies suggesting
that NO• may induce recombination in mammalian
cells. For example, patients who suffer from chronic in-
flammation associated with Crohn’s disease have in-
creased levels of sister chromatid exchange (SCE) in
their lymphocytes [20], though it is not known to what
extent NO• is responsible for this effect. In addition, two
studies have shown that mammalian cells exposed to
chemicals that give rise to NO• (“NO• donors”) suffer
increased levels of SCEs [21, 22], though the NO• do-
nors used in these studies also give rise to additional
potentially recombinogenic radical species. The obser-
vation that mammalian cells exposed to NO• have an
increased susceptibility to loss of heterozygosity pro-
vides additional support for the possibility that NO• in-
duces recombination [23]. Taken together, these obser-
vations suggest that NO• may induce homologous
recombination in mammalian cells. Here, we set out to
define the potential of NO• to induce homologous re-
combination in mammalian cells, and to explore the un-
derlying chemistry that might be responsible for its ef-
fects.
It is well established that the recombinogenicity of a
DNA damaging agent is dependent on the types of DNA
lesions that it induces. NO• reacts with oxygen and su-
peroxide to form N2O3 and ONOO−, respectively, which
are the dominant reactive nitrogen species formed un-
der physiological conditions (Figure 1A). Although NO•
does not directly damage DNA, N2O3 is a potent DNA
deaminating agent, and ONOO− is a potent DNA oxidiz-
ing agent. Most of the lesions created by N O are base2 3
Chemistry & Biology
358d
s
n
x
o
i
f
[
r
t
i
s
N
b
e
b
e
w
e
s
D
t
D
l
[
t
h
r
l
p
a
g
i
a
a
m
N
w
f
p
O
g
d
f
O
p
r
t
e
Figure 1. NO•/O2- or SIN-1-Induced Toxicity and Homologous Re-
combination in Mouse Embryonic Stem Cells
(A) Schematic depicting the major reactions of NO• secreted by b
activated macrophages. n
(B) The chromosomal direct repeat substrate. Expression cassettes V
are represented by large arrows with emphasis on the coding (
sequences (gray) and deleted regions (black). 5egfp and 3egfp s
expression are driven by the chicken β-actin promoter and cyto- c
megalovirus enhancer. Homologous recombination can lead to the (
restoration of full-length EGFP coding sequence and fluorescence o
expression. (
(C) Relative toxicity induced by exposure to the indicated doses of w
NO• delivered in the gas delivery chamber or SIN-1 as determined dnce of intracellular superoxide, it is not possible to
y colony forming assay. For NO• exposure, Ar gas was used as a
egative control, and relative survival was normalized accordingly.
alues are the mean of three samples ± SEM.
D) Relative levels of damage-induced recombination at a chromo-
omally integrated direct repeat. Fold induction of fluorescent re-
ombinant cells is shown. Following exposure to NO•/O2 or SIN-1
72 hr), cells were analyzed by flow cytometry. Values are the mean
f three samples ± SEM.
E) SCEs induced by SIN-1 and NO•/O2. SCEs per chromosome
ere detected by analyzing 20 metaphase chromosomes at each
ose. The results shown are mean ± SD for duplicate experiments.amages, while ONOO− attacks both the base and
ugar moieties of DNA [11]. For example, N2O3 deami-
ates DNA bases, creating lesions such as uracil, hypo-
anthine, and xanthine [24–27], and ONOO− oxidation
f guanine leads to 8-oxoguanine and its secondary ox-
dation products, 8-nitroguanine, as well as abasic sites
ormed by spontaneous depurination of 8-nitroguanine
27–31]. In addition to base lesions, ONOO− also di-
ectly induces direct single-strand breaks in DNA, by
he oxidative breakdown of deoxyribose [29, 32, 33].
Although double-strand breaks are thought to be crit-
cal for inducing homologous recombination, in vitro
tudies using purified DNA have shown that neither
2O3, nor ONOO− efficiently creates double-strand
reaks by direct reaction with DNA [32, 34, 35]. How-
ver, base lesions, abasic sites, and single-strand
reaks can be converted into double-strand breaks by
nzymatic processing (when in close proximity) or
hen they are encountered by the replication fork. For
xample, during base excision repair (BER), single-
trand breaks are created as repair intermediates by
NA glycosylases that have an associated AP lyase ac-
ivity and by AP endonucleases [36]. Consequently, if
NA glycosylases initiate BER of closely opposed
esions, double-strand breaks can be formed in vitro
37, 38]. Alternatively, DNA lesions that inhibit replica-
ion fork progression, such as BER intermediates, are
ighly recombinogenic in mammalian cells (e.g., see
eferences [39, 40]). Indeed, previous work from this
aboratory has demonstrated that DNA glycosylases
romote NO•-induced recombination in E. coli, presum-
bly by converting BER substrates into recombino-
enic double-strand breaks [41]. Furthermore, studies
n mammalian cells have recently shown that glycosyl-
ses promote radiation-induced strand breaks [42].
As a first step toward revealing the underlying mech-
nisms of NO•-induced sequence rearrangements in
ammals, we set out to reveal the chemical basis for
O•-induced recombination in mammalian cells. To-
ard this end, we compared the recombinogenic ef-
ects of the two predominant reactive nitrogen species
roduced under physiological conditions: N2O3 and
NOO−. For example, by exposing cells to NO• and O2
ases simultaneously in a specially designed NO• gas
elivery chamber [43], the major DNA damaging agent
ormed is N2O3. Alternatively, cells can be exposed to
NOO− using 3-morpholinosydnonimine (SIN-1), which
roduces equal amounts of superoxide and NO• that
apidly react to form ONOO−. However, in the case of
he NO• delivery chamber, due to the inevitable pres-
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359completely eliminate formation of some ONOO−. Simi-
larly, due to the presence O2 during SIN-1 exposure, it
is not possible to eliminate the possibility that some
N2O3 is formed. Thus the NO• delivery chamber and
SIN-1, which are amenable for studies of cultured cells,
provide effective strategies for creating conditions that
favor the formation of ONOO− or N2O3, although not
with absolute purity. In contrast, in vitro conditions can
be readily created in which plasmid DNA is virtually ex-
clusively exposed to either N2O3 or ONOO−. Therefore,
the combined approaches of studying chromosomal re-
combination in cells exposed to conditions that favor
formation of either N2O3 or ONOO−, and studying plas-
mid recombination between DNA molecules exposed
to conditions that give rise to exclusively N2O3 or
ONOO−, provide a powerful strategy for elucidating the
chemical nature of NO•-induced recombination in
mammalian cells.
Here, we show that exposure of mammalian cells to
conditions that favor formation of N2O3 is relatively
weakly recombinogenic, and that N2O3-induced DNA
lesions fail to induce interplasmid recombination. In
contrast, conditions that favored formation of ONOO−
are highly recombinogenic, both when cells are ex-
posed and when plasmid is exposed to ONOO− and
subsequently transfected into cells. By quantifying
strand breaks, abasic sites, and base lesions induced
by N2O3 and ONOO− in plasmid DNA, we demonstrate
that chemically induced strand breaks and oxidative
base lesions are far more recombinogenic than deami-
nated base lesions, even under conditions where the
quantity of N2O3-induced lesions exceeds that of
ONOO−-induced lesions. The results of these studies
contribute to our understanding of the biological con-
sequences of chronic inflammation and provide a
framework for delineating conditions that are most
likely to lead to tumorigenic sequence rearrangements
in people.
Results
SIN-1, but Not NO•/O2, Induces Homologous
Recombination at a Chromosomally
Integrated Direct Repeat
To study NO•/O2-induced homologous recombination
in mammalian cells, we used mouse embryonic stem
cells that carry a direct repeat substrate that yields a
fluorescent phenotype specifically as a result of mitotic
homologous recombination events [44]. The GF cells
carry expression cassettes for two different truncated
egfp cDNAs that are arranged in a direct repeat (Figure
1B; essential coding sequences were deleted from
either the 5# or the 3# end to create 5egfp and 3egfp,
respectively). In this system, recombination via several
different mechanisms can reconstitute the full-length
EGFP sequence (e.g., gene conversion, unequal sister
chromatid exchanges, and replication fork repair [14]).
Thus, recombination frequency can be readily esti-
mated by quantifying green fluorescent recombinant
cells by flow cytometry [44, 45].
To study the effects of ONOO− and N2O3, GF cells
were exposed to various concentrations of SIN-1 (to
deliver ONOO−) or to NO• and O gases delivered simul-2taneously via a Silastic tubing-based NO• delivery
chamber to deliver N2O3 (referred to as “NO•/O2” expo-
sure below) [43]. It is well established that for most DNA
damaging agents, the frequency of recombination rises
as the toxicity increases. Therefore, to compare the re-
combinogenic effects of ONOO− and N2O3, we estab-
lished conditions that induce similar levels of cytotoxic-
ity (Figure 1C). Cells were then exposed to equitoxic
doses of SIN-1 or NO•/O2 and were subsequently ana-
lyzed by flow cytometry to quantify fluorescent cells.
As can be seen in Figure 1D, SIN-1 is clearly recombi-
nogenic, inducing recombination up to w3-fold. It is
noteworthy that induction of recombination by SIN-1
initially increases and then decreases as a function of
dose, an observation that has also been noted by oth-
ers (e.g., reference [46]). In contrast to SIN-1, exposure
to NO•/O2 did not lead to any detectable increase in
the frequency of recombinant cells (Figure 1D), even at
doses that diminished survival to below 1% (data not
shown). Thus, while SIN-1 induces recombination at a
chromosomally integrated recombination substrate,
NO•/O2 does not.
SIN-1 Is a More Potent Inducer
of SCEs than NO•/O2
The chromosomal direct repeat assay offers a rapid
and effective measure of recombination at a single lo-
cus. To assess recombination throughout the genome
rather than at a single locus, we measured SCEs, which
are known to result from homologous recombination
events [47]. By culturing cells in the presence of BrdU
for two cell cycles, exchanges between differentially
stained sister chromatids can be visualized in meta-
phase spreads. For these experiments, cells were ex-
posed to either SIN-1 or NO•/O2, cultured in BrdU-con-
taining media for two cell doublings, and analyzed as
previously described [40]. As can be seen in Figure 1E,
SIN-1 significantly induces SCEs (w6-fold). In addition,
although significantly less recombinogenic than SIN-1,
NO•/O2 exposure induces SCEs (w2-fold). Although
these results suggest that N2O3 induces homologous
recombination, it is also possible that ONOO− that is
inevitably formed by reaction of NO• with intracellular
superoxide is responsible for this increase in SCE levels
in the NO•/O2-exposed cells.
Creation of an Interplasmid Recombination
Detection Assay
To further explore the relative recombinogenicity of
ONOO−- or N2O3-induced DNA lesions, we developed
an interplasmid recombination assay in which plasmids
can be exposed to pure ONOO− or to conditions that
generate exclusively N2O3 prior to transfection into the
cells. For this purpose, we used plasmids that carry
3egfp and 5egfp (Figure 2A). A recombination event
between these two plasmids can restore full-length
EGFP, yielding a fluorescent phenotype. To test the effi-
cacy of this approach, cells were transfected with
pEGFP, p3egfp, or p5egfp, or they were cotrans-
fected with both p3egfp and p5egfp. Whereas
w40% of the cells transfected with the positive control
pEGFP plasmid were significantly fluorescent, transfec-
tion with either p5egfp or p3egfp alone did not lead
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Figure 2. Interplasmid Recombination Assay in Mouse ES Cells and
bin COS 7L Monkey Kidney Cells
f(A) Schematic depicting the interplasmid recombination assay. Ex-
tpression cassettes are as described in Figure 1B.
l(B) Percent fluorescent cells following transfection with the indi-
cated plasmids. ES cells were analyzed by flow cytometry 48 hr b
after transfection. The pEGFP plasmid was used as a positive
control. I(C) Double-strand break-induced interplasmid recombination. The
Wp5egfp plasmid was linearized at the BamHI site indicated in (A).
aFold induction relative to control plasmid (uncut p5egfp) is shown.
T
p
(to any detectable EGFP expression (Figure 2B). How-
ever, when cells were cotransfected with p5egfp and N
Np3egfp together, we observed a significant number of
fluorescent cells, indicative of interplasmid homolo- v
wgous recombination (related assays have previously
been described; e.g., see references [48, 49]). E
tA time course experiment revealed that the number
of fluorescent cells cotransfected with p5egfp and r
tp3egfp increases over time, reaching a maximal level
byw48 hr, which subsequently begins to decline some- n
ttime after 72 hr posttransfection. This rise and fall in
the number of fluorescent cells likely reflects the time p
wrequired to achieve maximal expression of the EGFP
protein, followed by the inevitable loss of plasmid DNA i
tassociated with transient transfections. It is also note-
worthy that the cells that carry a single copy of the in- h
etegrated substrate fluoresce following homologous re-
combination (which shows that a single copy of an l
wEGFP expression cassette is sufficient to yield a de-
tectable fluorescent signal); however, it is not known s
Ehow many EGFP expression cassettes on extrachromo-
somal DNA are required for such a signal. t
sIn order to use this interplasmid assay to study the
relationship between DNA damage and recombination, l
nit is critical to control for transfection efficiency, sinceells that receive higher quantities of plasmid have an
ncreased chance of undergoing interplasmid recombi-
ation. Under the conditions of these experiments, we
ound that the transfection efficiency was highly con-
istent from sample to sample (less than a 10% varia-
ion among samples; data not shown). To control for
ransfection efficiency, the frequencies of interplasmid
ecombinant cells were normalized according to the
ercentage of fluorescent cells transfected with the
ositive control vector (see Experimental Procedures).
Double-strand breaks are known to be potent induc-
rs of homologous recombination, and it has previously
een shown that double-strand breaks in plasmids can
e repaired by recombining with homologous se-
uences available on another plasmid [48]. To maxi-
ize the sensitivity of the interplasmid assay for de-
ecting damage-induced recombination, we introduced
double-strand break into p5egfp using BamHI (Fig-
re 2A) and measured double-strand break-induced
ecombination under various conditions. Following
xtensive optimization, we found that we could in-
rease the sensitivity of the assay to damage-induced
ecombination by an order of magnitude by cotrans-
ecting damaged p5egfp with a 10-fold molar excess
f p3egfp (Figure 2C) and by transfecting cells via li-
ofection, as opposed to using other transfection
ethods (data not shown). Given that recombination
etween two copies of p5egfp can never reconstitute
ull-length EGFP coding sequences, conditions in which
here is a 10-fold molar excess of p3egfp increase the
ikelihood that recombination events will be detectable
y the appearance of a fluorescent signal.
nterplasmid Homologous Recombination Is Induced
hen Plasmid DNA Is Exposed to ONOO−
nd SIN-1, but Not to NO•/O2
o study the effects of ONOO−-induced DNA lesions,
5egfp was exposed to SIN-1 or to purified ONOO−
see Experimental Procedures). To study the effects of
2O3-induced DNA lesions, p5egfp was exposed to
2O3 in the NO•/O2 delivery chamber, as described pre-
iously [43]. The damaged p5egfp was then mixed
ith undamaged p3egfp and transfected into mouse
S cells. Although the frequency of recombination be-
ween plasmids could be assessed by quantifying fluo-
escent cells, if there are too many lesions, then even if
here is a productive recombination event, EGFP will
ot be expressed (e.g., due to inhibition of transcrip-
ion, concurrent mutations, or degradation of damaged
lasmid). To determine the optimal dose range, pEGFP
as exposed to various concentrations of the damag-
ng agents and then transfected into mouse cells, and
he proportion of fluorescent cells was assessed. The
ighest dose at which no significant inhibition of EGFP
xpression was observed was then taken as the upper
imit for studies of recombination (Figure 3A). It is note-
orthy that even at very high levels of NO•/O2 expo-
ure, we did not observe any significant inhibition of
GFP expression (Figure 3A, right). Therefore, we quan-
ified the number of lesions created under these expo-
ure conditions (described in detail below) and se-
ected an NO•/O2 dose range that creates a comparable
umber of lesions per plasmid compared to SIN-1 and
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361Figure 3. Interplasmid Recombination In-
duced by ONOO−, SIN-1, or NO•/O2-
Exposed Plasmid DNA
Results for mouse ES cells (A and B) and in
COS 7L monkey kidney cells (C and D) are
shown.
(A and C) Inhibition of EGFP expression
caused by pEGFP exposure to ONOO−, SIN-1,
or NO•. The frequency of fluorescent cells
was determined by flow cytometry 48 hr af-
ter transfection. Values indicate the averages
of two independent experiments (± SEM).
(B and D) Interplasmid recombination in-
duced by ONOO−, SIN-1, or NO•/O2-exposed
p5egfp. The p5egfp plasmid was exposed
to the indicated doses, mixed with undam-
aged p3egfp, and transfected into cells. Af-
ter 48 hr, the frequency of fluorescent cells
was analyzed by flow cytometry. In all the
experiments, frequencies were normalized
according to the lipofection efficiency. Val-
ues indicate two independent experiments,
each performed with duplicate samples
(± SEM).ONOO−. As can be seen in Figure 3B, DNA lesions in-
duced by ONOO− significantly induced homologous re-
combination (w2-fold) and DNA exposed to SIN-1 was
similarly susceptible to damage-induced recombina-
tion. However, DNA lesions created by NO•/O2 expo-
sure did not induce any increase in the frequency of
recombination (Figure 3B, right).Effects of ONOO−, SIN-1, and NO•/O2 on Interplasmid
Homologous Recombination Are Conserved
in Diverse Cell Types
A major advantage to studying damage-induced re-
combination using extrachromosomal plasmids is that
these experiments can be performed in different mam-
malian cell types. To determine if the observed effects
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iFigure 4. Interplasmid Homologous Recombination Induced by Ex-
posure of Cells to SIN-1 or NO•/O2 w
dResults for mouse ES cells (A and B) and COS 7L monkey kidney
ccells (C and D) are shown.
q(A and C) Relative toxicity induced by exposure to the indicated
Vdoses of NO• or SIN-1 as determined by colony forming assays.
dFor NO•/O2 exposure, Ar gas was used as a negative control, andfter transfection caused a dose-dependent induction
elative survival was normalized accordingly. Values are the mean
f three samples ± SEM.
B and D) Interplasmid recombination induced by SIN-1 or NO•/O2
n cells that carry p5egfp and p3egfp. Cells were colipofected
ith p5egfp and p3egfp 24 hr prior to exposure to the indicated
oses of SIN-1 or NO•. After 48 hr, the frequency of fluorescent
ells was quantified by flow cytometry. In all the experiments, fre-
uencies were normalized according to the lipofection efficiency.
alues indicate two independent experiments, each performed with
uplicate samples (± SEM).f ONOO−, SIN-1, and NO•/O2 on interplasmid homolo-
ous recombination are similar in other mammalian cell
ypes, we repeated these experiments using COS-7L
frican green monkey kidney cells. Despite the fact that
hese are very different cell types from two different
pecies, we saw remarkably similar dose-response
urves when we assayed for inhibition of EGFP expres-
ion (Figure 3C). Furthermore, although there are differ-
nces in the responses of these two cell types to dam-
ge-induced recombination (e.g., the minimal dose
equired to induce recombination), overall the relative
ecombinogenicity of these exposures is highly similar
Figure 3D).
xposure of Mammalian Cells to ONOO−
nd SIN-1, but Not to NO•/O2, Induces
xtrachromosomal Recombination
ne of the strengths of the interplasmid recombination
ssay is that by damaging the plasmid prior to transfec-
ion into cells, the effects of specific DNA lesions can
e studied. Another advantage of this assay is that it
an be readily adapted to many different cell types. Fi-
ally, in addition to introducing damage to the plasmids
rior to transfection, the cells can also be exposed to
amaging agents posttransfection to explore the possi-
ility that concurrent cellular responses to damage ex-
osure significantly modify the effects of DNA lesions
n recombination.
We have shown above that the relative recombino-
enicity of DNA lesions created by ONOO− and SIN-1
ersus NO•/O2 are similar in both mouse ES and mon-
ey COS 7L cells (Figure 3). We next asked if different
ell types would respond similarly when the cells them-
elves, rather than plasmid DNA, are exposed to SIN-1
nd NO•/O2. To select the appropriate dose range, we
irst established the dose-dependent survival of COS
L cells to SIN-1 or NO•/O2 (Figure 4C; note that Figure
A is the same as Figure 1C and is included here for
ase of comparisons). COS 7L cells appear to be more
esistant to the toxic effects of both SIN-1 and NO•
hen compared to mouse ES cells (compare Figures
A and 4C; note the change in the dose range).
To study interplasmid recombination in exposed
ells, we cotransfected cells with undamaged p5egfp
nd p3egfp and after 24 hr (to allow time for recovery
rom transfection), we exposed the cells to increasing
oncentrations of SIN-1 or to NO•/O2. After an addi-
ional 48 hr, the cells were analyzed by flow cytometry
note that similar results were observed in pilot experi-
ents assayed either 48 or 72 hr post damage expo-
ure). For both ES and COS 7L cells, exposure to SIN-1
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363Figure 5. Quantification of the Major Classes of DNA Lesions In-
duced by ONOO−, SIN-1, and NO•/O2 In Vitro and Comparison of
Lesion Levels to Recombination Levels
(A) Example of gel electrophoretic analysis in the plasmid nicking
assay used to quantify base and deoxyribose lesions. For technical
reasons, the plasmid nicking assays were performed with pSP189;
this plasmid is similar in size to p5egfp (both are w5 kb). Upper
panel: direct single-strand breaks produced in plasmid pSP189 by
ONOO− cause a dose-dependent shift from form I (supercoiled) to
form II (nicked, closed-circular plasmid). Lower panel: ONOO−-
treated plasmid DNA was reacted with Fpg to convert base lesions
and abasic sites to strand breaks. Fpg incubation causes the ap-
pearance of linear plasmid (form III). ONOO− concentrations are in
half-log steps.
(B) The brightness and contrast of lanes 8–11 in the bottom panelFpg glycosylase (Figure 5A, lane 1), there is very little
of (A) were adjusted to emphasize the appearance of form III DNA.
(C) Quantity of base damage (BD), abasic sites (AP), and single-
strand breaks (SSB) per 106 nucleotides as determined by plasmid
topoisomer analysis. Levels of base adducts were estimated by
converting base lesions to single-strand breaks using purified Fpg
glycosylase for ONOO− and SIN-1, or purified Ung and AlkA glyco-
sylases followed by putrescine cleavage of abasic sites for NO•/
O2. Mean ± SD for n = 4. Note that the base damage data for SIN-
1 and ONOO− has been previously reported [72].
(D) A comparison of the quality and quantity of lesions created by
the lowest recombinogenic dose of ONOO− and the highest dose
of NO•/O2. Graphs are identical to those in Figure 3B and are
shown here to facilitate comparison to damage levels.of recombination (Figures 4B and 4D). Importantly, the
same dose of SIN-1 resulted in a similar fold induction
in both cell types. For example, exposure to 1 mM SIN-1
induces an w2 fold increase in the frequency of recom-
bination in both cell types, regardless of whether the
exposure occurred before or after transfection (Figures
3B–3D). Therefore, it does not appear that cellular re-
sponses to damage exposure dramatically alter the
magnitude of SIN-1-induced interplasmid homologous
recombination (despite the differences in toxicity in
these cell types at the selected doses). Consistent with
the previous analysis of recombination between
p5egfp and p3egfp (e.g., Figures 1D and 3), we did
not observe any significant induction of recombination
when cells were exposed to NO•/O2. Thus, it again ap-
pears that DNA lesions induced by ONOO− are signifi-
cantly more recombinogenic than those induced by
NO•/O2.
ONOO−-Induced Direct Single-Strand Breaks
and Oxidative Base Lesions Are Recombinogenic
Reactive nitrogen species produce three major classes
of lesions: base damage, abasic sites, and single-
strand breaks. To gain a better understanding of how
these different classes of lesions affect homologous re-
combination, we used a well-established plasmid nick-
ing assay to quantify lesions generated when plasmid
is exposed to ONOO−, SIN-1, or N2O3 [24, 33]. Topoiso-
mer analysis was performed to quantify single-strand
breaks (by direct analysis of damaged plasmids), aba-
sic sites (which were converted to strand breaks using
putrescine), and base lesions (which were converted to
strand breaks using a combination of purified DNA gly-
cosylases and putrescine). The relative proportions of
supercoiled, relaxed, and linear plasmid molecules
were then used to calculate the number of DNA lesions
(see Experimental Procedures).
An example of an experiment in which the frequency
of Fpg-sensitive lesions was estimated is shown in Fig-
ure 5A. In the absence of Fpg, with increasing doses of
ONOO−, there is a gradual shift from form I (supercoiled
DNA) to form II (nicked closed-circular DNA), which re-
flects the ability of ONOO− to directly induce single-
strand breaks. Plasmid was then digested with purified
Fpg glycosylase, which both removes damaged bases
and cleaves the backbone via its associated lyase ac-
tivity [36]. In the case of control undamaged plasmid
DNA that was analyzed before and after incubation with
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364change in the ratio of supercoiled (form I) and nicked r
(form II) plasmid following digestion with Fpg (Fpg pro- d
duced a small amount of the plasmid nicking, most
likely as a consequence of cutting at background dam- d
age). In contrast, at the highest concentration of [
ONOO− (5 mM, far right lane), digestion with Fpg elimi- h
nates nearly all of the supercoiled form I DNA, indicat- p
ing that essentially all of the plasmids had at least one O
Fpg sensitive site. Importantly, it also appears that Fpg t
induces a small but detectable level of double-strand F
breaks, as indicated by the appearance of linear form t
III DNA, made more apparent by the adjustment in con- l
trast shown in Figure 5B. O
The ratio of forms I and II can be used to estimate s
the number of lesions per million nucleotides (although n
the total amount of DNA per lane can vary depending w
on loading, the ratio remains constant). Using this to- D
poisomer approach, we estimated the levels of chemi- q
cally induced single-strand breaks, abasic sites, and (
base lesions. The distinction between guanine oxida- t
tion products arising from ONOO− [50] and the nucleo- O
base deamination products arising from N2O3 [24] was p
achieved by differential recognition of the lesions by b
Fpg and Ung/AlkA, respectively (see Experimental Pro- D
cedures). We found that ONOO− creates primarily base F
damage and single-strand breaks, whereas SIN-1 cre- p
ates primarily single-strand breaks (Figure 5C). In con- a
trast, NO•/O2 exposure creates almost exclusively base D
lesions, with a small number of abasic sites and an un- m
detectable level of single-strand breaks, (Figure 5C), a
which is consistent with our published studies of the t
N2O3-induced DNA damage spectrum [24]. It is note- i
worthy that base lesions and abasic sites are masked t
by the presence of single-strand breaks in the topoi- t
somer assay. Thus, above 60 lesions per million nucleo- t
tides, there is more than one damage event per plasmid t
molecule on average (according to a Poisson distribu- s
tion), so that the calculated levels of damage underesti- n
mate the true level of damage (this is likely the reason b
for the appearance of a plateau in base damage levels
with doses of ONOO− above 0.01 mM; Figure 5C). This Dbehavior is independent of the identity of the DNA dam-
aging agent, however, so corrective measures are not
Inecessary when making comparisons of different agents,
tas in the present studies.
NIn order to gain a better understanding of the classes
gof lesions that lead to recombination, we compared the
vquantity and quality of lesions created by the lowest
rrecombinogenic dose of ONOO− (0.02 mM) to those
ccreated by the highest dose of NO• (2.7 mM·min) used
kfor the interplasmid recombination assay. Although 2.7
emM·min NO• creates more abasic sites and many more
Fbase lesions than 0.02 mM ONOO− (Figure 5D), NO•
swas not recombinogenic whereas ONOO− was highly
trecombinogenic. Importantly, NO• does not create any
odetectable single-strand breaks, whereas significant
nlevels of single-strand breaks were detected at recom-
cbinogenic doses of ONOO−. Note that the masking ef-
fect of single-strand breaks likely results in only a minor
runderestimate of the number of base lesions at 0.02
bmM ONOO−, so on a per lesion basis, ONOO− is more
wrecombinogenic than NO•. We therefore conclude that
nsingle-strand breaks induced by deoxyribose oxidation
and oxidatively damaged bases are significantly more becombinogenic than nucleobase deamination pro-
ucts in mammalian cells.
It is well established that double-strand breaks in-
uce homologous recombination in mammalian cells
51, 52]. Although DNA exposed to 0.2 mM ONOO− was
ighly recombinogenic, none of the plasmid DNA ap-
eared to have been linearized by exposure to 0.2 mM
NOO− (this dose falls between lanes 8 and 9 in the
op gel in Figure 5A). However, following digestion with
pg in vitro, double-strand breaks can be detected by
he appearance of linear DNA (see lanes 8 and 9 in the
ower gel of Figure 5A, and in Figure 5B). In contrast to
NOO−, digestion of NO•/O2-treated DNA with glyco-
ylases did not yield any detectable linear DNA (data
ot shown). Intriguingly, at 1–5 mM ONOO−, digestion
ith Fpg essentially eliminates the supercoiled form I
NA, and it is around this dose range that the fre-
uency of induced recombination appears to decline
compare 0.2 and 2 mM ONOO− in Figure 5D, left) and
he percentage of cells able to express EGFP from the
NOO−-treated positive control pEGFP vector starts to
lummet (Figures 3A and 3C). When DNA is transfected
y microinjection into mammalian cells, most of the
NA is rapidly degraded by cytosolic nucleases [53].
urthermore, it has been shown that whereas su-
ercoiled plasmid yields high levels of expression from
marker transgene 72 hr post lipofection, linearized
NA yields no detectable expression [54]. Given that
ammalian cells harbor multiple DNA glycosylases that
ct on a broad range of substrates [36, 55], it is likely
hat a much greater proportion of the damaged plasmid
s linearized by mammalian glycosylases following
ransfection than by Fpg digestion in vitro, rendering
he DNA vulnerable to nucleolytic degradation. Taken
ogether, these results suggest that following transfec-
ion, mammalian DNA glycosylases create double-
trand breaks that both induce homologous recombi-
ation and render the DNA vulnerable to degradation
y exonucleases.
iscussion
t has long been known that chronic inflammation con-
ributes to cancer. Although it is well established that
O• creates reactive nitrogen species that form muta-
enic DNA lesions [9, 10, 35], very few studies had in-
estigated the possibility that NO• induces homologous
ecombination events, even though homologous re-
ombination causes sequence rearrangements that are
nown to contribute to cancer [16, 18, 56]. Indeed, doz-
ns of known carcinogens are recombinogens [17, 19].
urthermore, people who are born predisposed to
pontaneously high levels of recombination are prone
o cancer [18, 19]. Thus, whether caused by exposure
r by an inherited predisposition, homologous recombi-
ation events are a form of genetic instability that can
ontribute to cancer.
Here, we have shown that ONOO−, the product of the
eaction of NO• with superoxide, causes highly recom-
inogenic DNA lesions. In contrast, when NO• reacts
ith oxygen to form N2O3, the resulting DNA lesions did
ot induce a detectable increase in interplasmid recom-
ination. Therefore, NO• becomes particularly recombi-
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365nogenic specifically under conditions where it reacts
with superoxide to create ONOO−. Importantly, NO• me-
diates both cell signaling and inflammation, but only
under conditions of inflammation does the body simul-
taneously create high levels of both NO• and superox-
ide. Therefore, it is likely that NO• does not significantly
induce recombination when produced at low concen-
trations during cell-signaling, whereas the results of the
present studies show that following reaction with su-
peroxide, it becomes highly recombinogenic and can
thus contribute to tumorigenic sequence rearrange-
ments.
We are primarily interested in the effects of inflamma-
tory chemicals on genomic stability under physiologi-
cally relevant exposure conditions. In the case of NO•/
O2, it has been estimated that the steady-state concen-
tration of NO• at sites of inflammation is %1 M [4, 57,
58]. In the studies described here, cells were exposed
to 1.3 M NO• (steady state), which is a reasonable
approximation of the level expected to be present
within inflamed tissues. In terms of ONOO−, we elected
not to expose cells to pure ONOO−, because if added
to the media, the result would be a bolus exposure that
does not accurately reflect conditions during inflamma-
tion (the half-life of ONOO− is w50 ms [59]). In contrast
to ONOO−, SIN-1 makes it possible to achieve longer
term exposures, since SIN-1 decomposes to form
ONOO− at a fairly steady rate (at least during the first
90 min of exposure [60]). At 1 mM SIN-1, ONOO− is
produced at a rate of w0.2 M/s [60], and in the studies
presented here, 0.5 mM SIN-1 significantly induced ho-
mologous recombination at the integrated direct repeat
substrate (note that this exposure was also relatively
nontoxic; see Figures 1C–1D). Although the exact con-
centrations of ONOO− at sites of inflammation are not
yet known, the conditions used in these experiments
are on par with the expected nanomolar to micromolar
range of ONOO− concentrations thought to be present
during inflammation [4].
Comparisons of ONOO−-induced recombination (re-
ported here) and ONOO−-induced mutations (reported
in the literature) suggest that ONOO− is similarly potent
as both a mutagen and a recombinogen. For example,
at a dose of SIN-1 that kills w75% of TK6 cells, muta-
tions at HPRT and TK are induced by w2-fold [23, 61],
whereas in the studies presented here, a dose of
SIN-1 that kills w25% of the cells induced a w3-fold
increase in recombination at a single locus in the chro-
mosomally integrated recombination substrate. These
results suggest that ONOO− may be as recombinogenic
as it is mutagenic, although further studies are required,
since toxicity does not necessarily directly reflect the
levels of damage. Comparing the studies presented
here to those in which exposed plasmid DNA has been
used to study mutagenesis (thus avoiding the complex-
ities of assessing damage levels in cells), we again
found similarities in the mutagenic and recombinogenic
effects of ONOO−. Specifically, in previous studies
using extrachromosomal plasmids, 2–2.5 mM ONOO−
induced a 4- to 9-fold increase in point mutations,
respectively [9, 33]. Here, we found that 0.02 mM
ONOO− induced a 2-fold increase in interplasmid re-
combination in mouse ES cells, and that 2 mM ONOO−
induced a 4-fold increase in interplasmid recombina-tion in monkey kidney cells. Although further studies
are necessary to control for cell-type effects, these
comparisons suggest that the mutagenic potential of
ONOO− is on par with its recombinogenic potential.
Although double-strand breaks are thought to be crit-
ical for inducing homologous recombination, ONOO−
creates oxidative base lesions, abasic sites, and single-
strand breaks [4]. Consistent with previous studies, in
the topoisomer analysis performed here, we were un-
able to detect the presence of any ONOO−- or SIN-1-
induced double-strand breaks at doses that were
highly recombinogenic. However, we have shown that
Fpg can introduce double-strand breaks in ONOO−-
treated plasmids (Figure 5A) and in SIN-1-treated plas-
mids (data not shown). In contrast, treatment with DNA
glycosylases did not induce double-strand breaks in
NO•/O2-treated plasmids (data not shown). Thus, fol-
lowing transfection, closely opposed lesions on oppo-
site strands could potentially be converted into double-
strand breaks by DNA glycosylases, as was originally
shown for oxidative damage in vitro and has been re-
cently demonstrated for radiation damage in mamma-
lian cells [37, 38, 42]. Alternatively, abasic sites and sin-
gle-strand breaks may be converted into double-strand
breaks during replication, which is likely to contribute
to SIN-1-induced recombination at the integrated direct
repeat. However, given that the plasmids used in these
experiments do not have an origin of replication, the
most likely cause of interplasmid recombination in-
duced by ONOO− are double-strand breaks created by
enzymatic processing in the recipient cells.
The results of these studies show that conditions that
favored formation of N2O3 did not induce recombina-
tion at any of the recombination substrates, although
there was a small but significant increase in sister chro-
matid exchanges in cells exposed to NO•/O2. It is cer-
tainly possible that some of the lesions induced by
N2O3 induce SCEs that were not detected using the en-
gineered substrates. However, due to the inevitable
presence of superoxide in normal cells, it is also pos-
sible that NO• reacts with superoxide to form ONOO in
these cells. Nevertheless, it is clearly the case that
ONOO− is significantly more recombinogenic than N2O3
in all of the recombination assays, and N2O3 lesions
failed to induce any detectable increase in interplasmid
recombination. These results were somewhat unex-
pected, given that lesions created by both N2O3 and
ONOO− are substrates for the base excision repair
pathway, and that base excision repair intermediates
have been shown to be highly recombinogenic in mam-
malian cells (e.g., [39, 40]).
One major difference between ONOO− and N2O3 is
that ONOO− can directly react with deoxyribose to in-
duce single-strand breaks. Therefore, it is possible that
chemically induced single-strand breaks are converted
into recombinogenic double-strand breaks when an-
other single-strand break is enzymatically introduced
on the opposite strand by base excision repair en-
zyme(s). Given that glycosylases rapidly find their
targets (t1/2 = minutes for the Aag DNA glycosylase, for
example [62]), it is not difficult to imagine that a glyco-
sylase might find its target before a chemically induced
strand break on the opposite strand has been repaired.
Furthermore, different types of glycosylases act on
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366ONOO−-induced guanine oxidation and nitration pro-
ducts (e.g., 8-nitroguanine, 8-oxoguanine and its se- s
condary oxidative products) compared to N2O3-induced t
nucleobase deamination products (uracil, xanthine, and w
hypoxanthine [50, 63]; M.D. et al., in preparation). The 
vast majority of ONOO−-induced lesions are repaired by c
bifunctional glycosylases (Fpg and Nth, and their mam- t
malian homologs), and these enzymes have the ability f
both to remove the base lesions and to cleave the r
sugar-phosphate backbone (i.e., via their associated ly- l
ase activity) [64, 65]. In contrast, those glycosylases l
known to act on N2O3-induced lesions are monofunc- e
tional (e.g., Ung and AlkA, and their mammalian homo- i
logs [63, 66]; M.D. et al., unpublished data), so these r
enzymes remove the base lesions but cannot create b
single-strand breaks. Taken together, the observation m
that ONOO− is more recombinogenic than N2O3 may be c
because bifunctional glycosylases can create recombi- g
nogenic double-strand breaks by cleaving across from
a pre-existing chemically-induced strand break and by S
enzymatic cleavage at two closely opposed base lesions.
Although deaminated bases are known to be muta- H
genic [27], we did not find that EGFP expression was c
inhibited by exposure to NO•/O2. At the highest dose c
of NO•/O2, we estimated that there arew2 lesions/plas- e
mid. Given that only w15% of the plasmid sequences n
code for EGFP, it is likely that copies of the plasmid m
that harbor undamaged coding sequences are respon- a
sible for the observed EGFP expression. Unexpectedly, t
we found that an even lower number of ONOO− lesions/ s
plasmid inhibited EGFP expression. Following the same i
logic, it seems unlikely that EGFP expression is sup- f
pressed by mutagenic damage to coding sequences. t
Given that linearized plasmid DNA is highly vulnerable p
to degradation by exonucleases [53, 54], one possibility T
is that EGFP expression is suppressed due to plasmid s
loss, rather than to mutations. Thus, the observations N
that suppression of EGFP and induction of recombina- t
tion go hand in hand for ONOO− and SIN-1, and that
r
NO•/O2 neither suppresses EGFP nor induces recombi- c
nation, are consistent with a model wherein glycosyl-
cases introduce double-strand breaks that both increase
sthe vulnerability of the DNA to degradation and induce
thomologous recombination.
mOne interesting result of these studies was that the
irelative recombinogenicity of ONOO− and N2O3 is very tsimilar in mouse embryonic cells and monkey kidney
hcells, regardless of whether the DNA was exposed prior
sto transfection, or cells were exposed after transfec-
dtion. However, there are also some subtle differences.
iFor example, there is a significant difference in the
doses of ONOO− required to achieve maximal induction
Eof recombination in embryonic cells versus kidney cells
(Figure 3). Although there are many possible explana- C
tions for this observation, one possibility is that embry- M
onic stem cells have relatively higher levels of DNA gly- t
acosylase that induce double-strand breaks. If this were
nthe case, then glycosylase-induced double-strand
kbreaks could potentially be induced at lower levels of
1adducts. Although ONOO−-induced recombination is a
general feature of mammalian cells, these results show

that the relative sensitivity of cells to ONOO−-induced E
recombination clearly is variable among different cell c
otypes.The magnitude of ONOO−-induced recombination is
ignificant. Mammalian cells subjected to conditions
hat favor formation of ONOO− are susceptible to an
3-fold increase in recombination at the integrated
GF recombination substrate, and to an w6-fold in-
rease in SCEs. For comparison, it has been reported
hat phenytoin, an oxidizing agent, induces a 2- to 3-
old increase in recombination at an analogous direct
epeat substrate in CHO cells [67]. Indeed, in the SCE
iterature, most of the agents that induce such high
evels of SCEs are chemicals that most of us will never
xperience [68]. Given that inflammation is unavoidable
n the lifetime of most people, and that ONOO− is highly
ecombinogenic, endogenously produced ONOO− may
e one of the most significant recombinogens to which
ost people are exposed. As such, ONOO−-induced re-
ombination may be an important risk factor for tumori-
enesis.
ignificance
omologous recombination events are an important
lass of mutations that are likely to be the underlying
ause of one or more mutations in every tumor. Nev-
rtheless, we do not yet know what causes recombi-
ation in people. Although exposure to toxic levels of
ost carcinogens is recombinogenic, most humans
re not likely to be exposed to high concentrations of
hese agents. In contrast, inflammation is a wide-
pread pathophysiological response in humans, and
t is known to contribute to cancer. Indeed, during in-
lammation, the high levels of reactive oxygen and ni-
rogen species that are produced by activated macro-
hages are highly toxic to neighboring normal cells.
he major physiologically relevant reactive nitrogen
pecies are N2O3 and ONOO−, which are formed when
O• reacts with either oxygen or superoxide, respec-
ively. Here, we have shown that ONOO− is a strong
ecombinogen, whereas N2O3 is relatively weakly re-
ombinogenic. Consequently, NO• becomes highly re-
ombinogenic specifically under conditions when
uperoxide is present, as is the case during inflamma-
ion. Measurements of ONOO−-induced sister chro-
atid exchange, recombination at a chromosomally
ntegrated direct repeat, and interplasmid recombina-
ion definitively show that ONOO−-induced lesions are
ighly recombinogenic. Taken together, these results
uggest that ONOO−-induced recombinogenic DNA
amage may play an important role in inflammation-
nduced cancers.
xperimental Procedures
ell Culture
ouse embryonic stem cells (J1) were maintained in DMEM con-
aining 10% fetal bovine serum, L-glutamine, nonessential amino
cids, β-mercaptoethanol, and leukocyte inhibitory factor on gelati-
ized dishes without feeders. The COS-7L African green monkey
idney cell line (Invitrogen) was maintained in DMEM containing
0% fetal bovine serum and L-glutamine.
GF Cells
mbryonic stem cells were engineered to carry a direct repeat re-
ombination substrate integrated at the ROSA26 locus. The design
f this substrate is similar to that of the FYDR substrate [46], ex-
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367cept that reconstitution of full-length coding sequences leads to
expression of enhanced green fluorescent protein (rather than yel-
low fluorescent protein). This recombination detection system will
be more fully described elsewhere [44].
SIN-1 Treatment of Cells
Cells were plated in complete medium 24 hr prior to treatment.
Cells were exposed to the indicated doses of SIN-1 (Biomol Re-
search Laboratories) in Dulbecco’s PBS supplemented with 25 mM
sodium bicarbonate (pH 7.4), at 37°C. Exposure of cultures to air
was provided by shaking for 5 min every 10 min for 90 min, as
described previously [61]. After treatment, cultures were rinsed in
PBS and incubated in fresh medium.
NO• Treatment of Cells
Cells were plated at a density of 0.5–2 × 106 cells per 60 mm dishes
in complete medium. After 24 hr, log phase cells were exposed to
10% NO•/90% Ar gas mixture (BOC Gas Co.) which was passed
through 7 cm of Silastic tubing in the NO• delivery chamber, as
previously described [43]. A 50% O2/45% N2/5% CO2 gas mixture
(BOC Gas Co.) was passed through a second 7 cm long tube to
maintain the O2 level in the medium. These conditions produced
steady-state levels of O2 and NO• that are approximately those that
are experienced under physiological conditions (NO• steady-state
levels in these experiments are 1.84 M; physiological levels are
on the order of w1 M) [4, 57, 58]. The control cells were exposed
to 100% Ar gas under the same conditions as NO• exposure. At
the end of treatment, cells were washed and incubated in fresh
complete medium.
Colony Forming Assay
Following treatment with SIN-1 and NO•/O2, cells were harvested
by trypsinization, counted, and plated at a density of 100 cells/100
mm tissue culture dishes. After a week of culture, the colonies were
fixed with ethanol, stained with trypan blue, and counted. Experi-
ments were performed in triplicate and all experiments were per-
formed three or more times.
SCE Assay
J1 cells were seeded at a density of 1 × 106 per 100 mm dish
for SIN-1 treatments, and at 0.5 × 106 per 60 mm dish for NO•/O2
treatment. After 24 hr, log phase cultures were exposed to SIN-1
and NO•/O2 as described above. After exposure, cells were washed
and incubated in fresh McCoy’s 5A media (Invitrogen) supple-
mented with 10 M BrdU. After 24 hr, Colcemid (0.1 g/ml; Invitro-
gen) was added to the medium for an additional 3 hr. Metaphase
spreads were prepared, and sister chromatids were differentially
stained as previously described [40]. Experiments were performed
in duplicate, and 20 metaphase spreads were counted per data
point.
Chromosomal Direct Repeat Assay
Between 0.5 and 2.5 × 105 GF cells were seeded onto six-well
dishes for SIN-1 treatments, and onto 60 mm tissue dishes for NO•/
O2 treatment. After 24 hr, log phase cells were exposed to the indi-
cated doses of cytotoxic agents, as described above. After 72 hr
(w3.25 population doublings in control cells), cells were harvested
by trypsinization and analyzed by flow cytometry to determine the
frequency of fluorescent cells.
Plasmid Construction to Generate Recombination Substrates
The PstI-BamHI fragment in pCX-EGFP (gift of M. Okabe [69]) was
replaced with a synthetic adaptor carrying NsiI, NotI, and XhoI sites
to create pCX-NNX-EGFP. Full-length and truncated coding se-
quences were PCR amplified using primers that carry synthetic
ApoI sites and subcloned between the EcoRI sites of pCX-NNX to
create pCX-NNX-5egfp (abbreviated as p5egfp) and pCX-NNX-
D3egfp (abbreviated as p3egfp). The p5egfp plasmid carries a
99 bp deletion from the 5# end, and p3egfp carried an 81 bp dele-
tion from the 3# end of the open reading frame. There are 540 bp
of overlap between the deletions. Stop codons were placed after
and before these cassettes, respectively, to prevent read-through
translation products. Plasmid DNA was purified using the Qiagenplasmid purification kit. Restriction enzymes were from New Eng-
land Biolabs. Oligonucleotides were from Amitof, Inc. (Allston, MA).
Oligonucleotide and plasmid sequences are available upon re-
quest.
ONOO−, SIN-1, and NO• Treatment of Plasmid DNA
ONOO− was synthesized by ozonolysis of sodium azide [70], and
the concentration of the stock solution was measured by UV imme-
diately prior to treatment (e302 = 1670 M−1 cm−1). Bolus exposure to
ONOO− was achieved by placing a droplet of the ONOO− stock
solution on the side wall of a microcentrifuge tube containing plas-
mid DNA (2.5 g in 50 l) in 150 mM potassium phosphate/20 mM
sodium bicarbonate buffer (pH 7.4 ) followed by vigorous vortexing
to mix the solutions. For SIN-1, plasmid DNA (5 g in 100 l) was
treated in 150 mM potassium phosphate/20 mM sodium bicarbon-
ate buffer (pH 7.4) at 37°C for 90 min. For NO• treatment, plasmid
DNA (20 g/ml) was exposed in the NO• delivery chamber under
the same conditions as used for the cell exposures (see above).
The NO• dose was controlled by removing samples at various times
during exposure. For all treatments, after exposure, the DNA was
recovered by ethanol precipitation, resuspended in PBS, and quan-
tified by UV spectrometry.
Interplasmid Recombination Assay
Extracellular DNA Exposure
J1 and COS-7L cells were plated at a density of 4 × 104 cells per
well in 24-well plates. After 24 hr, 0.1 g p5egfp (± exposure to
DNA damage) and 1 g p3egfp plasmids were colipofected into
the cells by using Lipofectamine 2000 (Invitrogen) in a total volume
of 0.5 ml. To assay inhibition of EGFP expression, 0.1 g of pEGFP
was treated with the indicated doses of these agents prior to lipo-
fection. Transfection efficiency in each experiment was measured
by simultaneous lipofection of 0.1 g pEGFP in three independent
samples. To keep DNA concentrations constant, 0.1 g of dam-
aged pLacZ (Clontech) was used in lieu of damaged p5egfp, and
1 g of pLacZ was used in lieu of p3egfp. For all experiments,
cells were trypsinized 48 hr post-lipofection and analyzed by flow
cytometry to determine the frequency of fluorescent cells.
Intracellular DNA Exposure
J1 and COS-7L cells were plated at a density of 4 × 104 cells per
well in six-well plates. After 24 hr, 0.3 g p5egfp and 0.3 g
p3egfp plasmids were colipofected into the cells in a total volume
of 1 ml as described above. After 24 hr, cells were treated with
SIN-1 or NO•/O2 as described above. Cells were analyzed by flow
cytometry 48 hr posttreatment. The transfection efficiency was
tested by simultaneous lipofection of 0.3 g pEGFP into three inde-
pendent samples.
Flow Cytometry
Pelleted cells were resuspended in OptiMEM (GIBCO/BRL) and
passed through a 70 m filter (Falcon) prior to analysis on a Becton
Dickinson FACScan flow cytometer (excitation 488 nm, argon laser;
emission 580/30). Live cells were gated according to forward and
side scatter.
Quantification of DNA Damage by Plasmid
Topoisomer Analysis
A plasmid nicking assay was used to quantify the DNA deoxyribose
and base damage. For lesion quantification, similar results were
obtained using either the p5egfp or the plasmid pSP189. The lat-
ter is a pBR-based, 4952 bp plasmid, which is similar in size to
p5egfp (4921 bp), which allows interchangeability of the two plas-
mids in the nicking assay. After ONOO−, SIN-1, or NO•/O2 treat-
ments, a portion (200 ng) of the DNA was treated with putrescine
(100 mM [pH 7.0], 1 hr, 37°C) to convert all types of abasic sites to
strand breaks [51, 71]. Another portion (200 ng) was kept on ice as
a control for the direct strand breaks. To quantify the oxidative base
lesions formed by ONOO− or SIN-1, a third portion of the DNA sam-
ple was treated with E. coli formamidopyrimidine-DNA glycosylase
(Fpg) (Trevigen) to convert oxidized purines to strand breaks. More
than 90% of the ONOO− guanine oxidation products in DNA are
recognized by Fpg [50]. Fpg treatment was performed in a volume
of 10 l containing 200 ng of ONOO−-treated DNA, 1 l of Fpg
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368(w1.5 units) and buffer containing 10 mM Tris-HCl (pH 7.5), 1 mM 1
EDTA, and 100 mM NaCl at 37°C for 1 hr. Fpg was then removed
by phenol/chloroform extraction. Similarly, to quantify nucleobase
1deamination products formed by NO• in the presence of O2 (e.g.,
N2O3), plasmid DNA samples were incubated with E. coli Ung DNA
glycosylase (Trevigen) and the E. coli AlkA DNA glycosylase (Phar-
mingen), followed by putrescine treatment to convert the resulting 1
abasic sites to strand breaks. Both xanthine and hypoxanthine
have been shown to be recognized by AlkA ([63]; M.D. et al., un-
1published data). Crossreactions of AlkA/Ung with ONOO−-treated
DNA and Fpg with N2O3-treated DNA revealed <5% additional
strand breaks, which demonstrates the specificity of these en-
zymes for the specific sets of lesions caused by N2O3 and ONOO−.
The recovered DNA was redissolved in H2O, and plasmid topoi-
somers were resolved by 1% agarose slab gel electrophoresis in 1
the presence of 0.1 g/ml ethidium bromide. The quantity of DNA
in each band was determined by fluorescence imaging (Ultra-Lum).
1For lesion quantification, similar results were obtained using either
the p5egfp or the pSP189 plasmid (provided by Dr. M. Seidman;
1NIH, Bethesda, MD), with the pSP189 plasmid used for the experi-
ments presented in Figure 5. Note that the base damage data for
SIN-1 and ONOO− has been previously reported [72].
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